KEAP1 and breast carcinoma: It is likely to be a state where GR pathway and Nrf-2 (if keap1 is not mutated in breast cancer) both remain suppressed under oxidative stress, as may be the case of low SULT1E1 expression in a few breast tumors (Fig. 3).